• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Comment to "Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis".对《原发性乳腺癌与相应转移灶之间具有一致三阴性表型的患者预后不良》的评论
J Breast Cancer. 2016 Dec;19(4):465. doi: 10.4048/jbc.2016.19.4.465. Epub 2016 Dec 23.
2
Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis.原发性乳腺癌与相应转移灶之间具有一致三阴性表型的患者预后较差。
J Breast Cancer. 2016 Sep;19(3):268-274. doi: 10.4048/jbc.2016.19.3.268. Epub 2016 Sep 23.
3
Pattern of metastatic spread in triple-negative breast cancer.三阴性乳腺癌的转移扩散模式。
Breast Cancer Res Treat. 2009 May;115(2):423-8. doi: 10.1007/s10549-008-0086-2. Epub 2008 Jun 10.
4
Beyond triple-negative breast cancer: the need to define new subtypes.超越三阴性乳腺癌：需要定义新的亚型。
Expert Rev Anticancer Ther. 2010 Aug;10(8):1197-213. doi: 10.1586/era.10.50.
5
Impact of triple negative phenotype on prognosis and early onset of breast cancer in Iranian females.三阴性表型对伊朗女性乳腺癌预后及早期发病的影响。
Asian Pac J Cancer Prev. 2011;12(3):719-24.
6
Increased expression of osteopontin in patients with triple-negative breast cancer.三阴性乳腺癌患者骨桥蛋白表达增加。
Eur J Clin Invest. 2008 Jun;38(6):438-46. doi: 10.1111/j.1365-2362.2008.01956.x. Epub 2008 Apr 30.
7
[Breast cancer with triple-negative phenotype in the Russian patient population. Clinical and morphologic features].[俄罗斯患者群体中的三阴性乳腺癌表型。临床和形态学特征]
Vopr Onkol. 2015;61(2):189-94.
8
Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.基底细胞角蛋白和表皮生长因子受体的表达与三阴性乳腺癌女性的 BRCA1 突变状态无关。
Am J Surg Pathol. 2009 Jul;33(7):1093-7. doi: 10.1097/PAS.0b013e31819c1c93.
9
Triple negative breast cancer in North of Morocco: clinicopathologic and prognostic features.摩洛哥北部的三阴性乳腺癌：临床病理及预后特征
BMC Womens Health. 2016 Oct 22;16(1):68. doi: 10.1186/s12905-016-0346-y.
10
Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases.三阴性和 HER2 过表达型乳腺癌具有更高的颅内转移风险和更早的发生。
Eur J Cancer. 2009 Nov;45(16):2792-8. doi: 10.1016/j.ejca.2009.06.027. Epub 2009 Jul 28.

本文引用的文献

1
Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis.原发性乳腺癌与相应转移灶之间具有一致三阴性表型的患者预后较差。
J Breast Cancer. 2016 Sep;19(3):268-274. doi: 10.4048/jbc.2016.19.3.268. Epub 2016 Sep 23.
2
Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials.辅助内分泌治疗对激素受体阳性、人表皮生长因子受体2阴性的绝经前早期乳腺癌女性的绝对获益：TEXT和SOFT试验
J Clin Oncol. 2016 Jul 1;34(19):2221-31. doi: 10.1200/JCO.2015.64.3171. Epub 2016 Apr 4.
3
A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors.大多数低（1-10%）ER 阳性乳腺癌的行为类似于激素受体阴性肿瘤。
J Cancer. 2014 Jan 23;5(2):156-65. doi: 10.7150/jca.7668. eCollection 2014.
4
Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trials.绝经前内分泌反应型早期乳腺癌女性的辅助治疗：TEXT和SOFT试验设计
Breast. 2013 Dec;22(6):1094-100. doi: 10.1016/j.breast.2013.08.009. Epub 2013 Oct 2.
5
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).美国临床肿瘤学会/美国病理学家学会关于乳腺癌雌激素和孕激素受体免疫组织化学检测的指南建议（未删节版）。
Arch Pathol Lab Med. 2010 Jul;134(7):e48-72. doi: 10.5858/134.7.e48.
6
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.美国临床肿瘤学会/美国病理学家学会关于乳腺癌雌激素和孕激素受体免疫组织化学检测的指南建议。
J Clin Oncol. 2010 Jun 1;28(16):2784-95. doi: 10.1200/JCO.2009.25.6529. Epub 2010 Apr 19.
7
Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry.雌激素受体（ER）阴性、孕激素受体（PR）阴性和人表皮生长因子受体2（HER2）阴性浸润性乳腺癌（即所谓的三阴性表型）的描述性分析：一项基于加利福尼亚癌症登记处数据的人群研究
Cancer. 2007 May 1;109(9):1721-8. doi: 10.1002/cncr.22618.
8
Prognostic markers in triple-negative breast cancer.三阴性乳腺癌的预后标志物
Cancer. 2007 Jan 1;109(1):25-32. doi: 10.1002/cncr.22381.

Comment to "Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis".

作者信息

Altundag Kadri

机构信息

Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.

出版信息

J Breast Cancer. 2016 Dec;19(4):465. doi: 10.4048/jbc.2016.19.4.465. Epub 2016 Dec 23.

DOI:10.4048/jbc.2016.19.4.465
PMID:28053637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5204055/
Abstract
摘要